> ALGN stock

Stay informed on ALGN stock with the most important news summaries, insider trading, valuation highlights and analyst recommendations

ALGN stock news: A summarized overview for you, just the bottom line of the most recent news items!

Last Updated: May 09, 2024

Top 3 Med Tech Stocks Poised for Growth, Featuring ALGN
- Buckle up, investors! Align Technology is on a teeth-straightening tear with a jaw-dropping 21% spike in Q4 revenue. Thank the stars for our never-ending quest for perfect smiles, because ALGN's clear aligners and iTero scanners are leading the charge.
- In a move that's about as smooth as their aligners, ALGN's brainy play on snapping up exocad and Medacta is more than just adding tech trophies to their shelf. It's a strategic masterstroke fueling their growth, showing they're not just about straightening teeth but positioning themselves as innovators in the dental game.
- Hey, market watchers, keep your eyes peeled on ALGN! Analysts are flashing their bullish signals loud and clear, seeing a bright future in the booming demand for clear aligners. It's not just about a pretty smile in the orthodontic lane; it's shaping up to be a restorative market dazzler too.
Align Technology's 2023 Performance Against Other Med Stocks
- Align Technology is all smiles, boasting a 7% leap in shares, thanks to a dental-demand-driven bonanza. The spotlight? Their Q4 glittering earnings reveal, powered by the unstoppable charm of Invisalign clear aligners.
- Earnings aren't just aligning; they're outshining. Align Tech's net income didn't just meet the bar; it pole-vaulted over it, with a revenue uptick to 9.5% organic growth that's teeth-chatteringly above pre-pandemic highs.
- Expansion is the name of the game, and Align's not playing it coy. Strengthening its throne in clear aligner sovereignty, the firm's growth game is sturdy, forecasting sunny days ahead for its portfolio (and your investments).

Real-time price chart of ALGN stock

Stay up-to-date with the latest performance of Align Technology, (ALGN) through our real-time stock chart, providing live insights into its market movements

ALGN stock valuation - less noise, just the highlights

ALGN's PEG ratio of 3.85, when considered alongside its anticipated EPS growth over the next 5 years of 11.70%, reinforces the stock's appeal to investors and traders who focus on growth-adjusted valuation metrics. Although the PEG ratio might appear higher, the expected growth rates provide a fuller picture, underscore the company's promising growth prospects relative to its price, and offer a nuanced view on Align Technology valuation. This blend of growth expectations and valuation metrics presents ALGN as an attractive option for investors looking for long-term gains in their portfolio.
The forward P/E ratio of Align Technology (ALGN) stands at 24.90, indicating that investors and traders expect the company's earnings to grow in the future. This makes ALGN an attractive investment for those looking for growth in the dental and orthodontic sectors. A lower forward P/E compared to the current P/E of 45.09 suggests that ALGN's earnings are expected to increase, signifying potential growth and making it a compelling valuation aspect of Align Technology.
Align Technology demonstrates strong future prospects with an EPS growth next year projected at 13.95%. This indicates a robust growth trajectory for ALGN's earnings per share, making it an appealing stock for investors seeking to benefit from advancing earnings in the booming dental equipment sector. This EPS growth expectation contributes to a positive outlook on ALGN valuation, highlighting the company's potential for increased profitability.

Stay informed with the latest ALGN stock analyst recommendations:

Recent initiation by Leerink Partners with a Market Perform rating and a price target of $310 showcases a fresh perspective on ALGN stock, offering investors insights into Align Technology's current valuation and market position. This newly introduced outlook provides a pivotal benchmark for ALGN's perceived stability and growth potential, centralizing the ALGN analyst recommendation discussion around up-to-date analyst sentiment.
A comprehensive view on ALGN's analyst recommendations over time, from downgrades to upgrades, showcases the dynamic and fluctuating nature of market sentiments toward Align Technology Inc. By focusing on the diverse analyst outlooks and price target changes, investors and traders can navigate the complexities of market predictions, ensuring a more informed and nuanced approach to ALGN stock investment strategies.
The latest actions by major financial institutions, including an upgrade from Goldman from Sell to Neutral with a significant price target increase from $165 to $307, signal a noteworthy shift in market conviction. This pivot plays a crucial role for investors analyzing Align Technology analyst recommendations, indicating an improved outlook on the company's financial health and market strategy that could influence investor confidence and trading decisions.

Stay updated on ALGN stock insider trading with these key points:

Legal and Operational Insights: Insider trading by EVP, Chief Legal & Regulatory Julie Ann Coletti and EVP, Global Operations Emory Wright, involves both option exercises and sales. Insider transactions by executives in key operational and legal roles can provide nuanced insights into the company's operational health and regulatory positioning. Such insider activity requires careful interpretation, as it could signal aligning personal gains with expected stock performance or adjustments based on the company's internal developments.
Increased Activity by Key Executives: Notable insider trading activity in ALGN includes the President and CEO, Joseph M. Hogan, exercising options and making significant purchases in late 2023, indicating strong confidence in the company's future. This type of insider buying can be a positive signal to investors and traders, suggesting that the company's leadership believes the stock is undervalued or that strong growth prospects lie ahead.
High-Level Sales: Recent insider transactions feature substantial sales by directors, such as Joseph Lacob, with sales over $7 million in early 2024. While insider sales can sometimes signal that insiders believe the stock is fully valued, context matters; sales could also relate to personal financial planning rather than a lack of confidence in the company's prospects. Investors should view such sales in conjunction with other insider activities and company performance indicators.

ALGN technical analysis

Unlock insights to make smarter investment decisions with this real-time technical analysis tool. Dive in to see the latest buy and sell signals tailored for today's dynamic market. Get the market's inside scoop in a flash! Peek at our fun and user-friendly ratings to see what it is whispering about your ALGN stock, within various timeframes.

Join the Discussion: What's your outlook on ALGN stock's performance?

Are you considering investing in ALGN or have you already done so? Share your thoughts below with the investor and trader community at ForexLive.com, share your angles, analysis, predictions, or questions about ALGN in the comments below! Your input matters to us.

Please note that this content regarding ALGN stock is for informational purposes only, includes opinions and not recommendations, and is not intended as investment or trading advice; invest in and/or trade ALGN at your own risk only.

Explore additional stocks:

Discover Alaska Air Group stock with its new summaries, insider trading, valuation highlights and analyst recommendations

Contact us
Newsletter

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}